Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Morgan Stanley from $26.00 to $28.00. They now have an "underweight" rating on the stock.
Veracyte, Inc. (NASDAQ: VCYT) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $50.00 price target on the stock.
Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Scotiabank from $40.00 to $44.00. They now have a "sector outperform" rating on the stock.
Veracyte Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]